West Pharmaceutical Services, Inc. (WST) Q1 2012 Earnings Results

West Pharmaceutical Reports EPS of $0.83, Stock Up 1.44%

West Pharmaceutical's earnings report showed an EPS of $0.83, which met expectations. The stock reacted positively, rising 1.44%, likely due to the company's focus on operational stability. Investors may view this as a sign of resilience in the current market conditions.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.83	N/A	+0.00%

Management

Management commentary

Tone: Neutral

Overall, management expressed a steady outlook without providing specific guidance. They focused on operational stability and quality.

Management highlighted the stability in their operations during the quarter.

They emphasized their commitment to maintaining quality and efficiency.

West Pharmaceutical Reports EPS of $0.83, Stock Up 1.44%

Key numbers

Management commentary

West Pharmaceutical Services, Inc.

More earnings this week

West Pharmaceutical Reports EPS of $0.83, Stock Up 1.44%

Key numbers

Management commentary